Literature DB >> 1902562

A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.

M G Wientjes1, J T Dalton, R A Badalament, B M Dasani, J R Drago, J L Au.   

Abstract

Determination of the depth of penetration of locally applied drug therapy and evaluation of possible mechanisms of drug transport require knowledge of drug concentration-versus-tissues depth profiles. A method to determine the drug concentration-depth profile is needed. We have devised such a method and used it to determine the penetration of mitomycin C (MMC) in the dog bladder wall after intravesical drug instillation. This method is based on sectioning of frozen tissue into 40-microns segments, followed by drug extraction and high-pressure liquid chromatography analysis. Tissue concentrations could be detected with a sensitivity of 1 ng/sample, or 20 ng/g for tissue samples of approximately 2 x 2 cm. This sensitivity was sufficient to describe the penetration of MMC in the bladder wall of dogs, using an identical instillation technique, dwell time, and MMC concentration as in human patients. Tissue concentrations were expressed relative to tissue weight or tissue protein contents. For MMC, standardization to tissue weight yielded a better mathematical fit of the concentration-versus-depth profiles than standardization to protein content. The time interval between tissue harvesting and freezing was critical. The MMC concentration at the urothelial side of dog bladders was 2- to 10-fold higher in samples processed immediately after harvesting, compared to samples processed after 1 hr or longer. This significant decrease was not due to drug metabolism in situ. In separate in vitro experiments, we found that the degradation of MMC in 8% tissue homogenate was relatively slow, with only a 30% decline in concentration over 24 hr.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902562     DOI: 10.1023/a:1015827700904

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Penetration of vitamin A acid into human skin.

Authors:  H Schaefer; A Zesch
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1975 Jan 27-29

2.  Mechanisms of corneal drug penetration. III: Modeling of molecular transport.

Authors:  G M Grass; E R Cooper; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

3.  Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Authors:  R J Scheuplein
Journal:  J Invest Dermatol       Date:  1965-11       Impact factor: 8.551

4.  Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

5.  A distributed model of peritoneal-plasma transport: tissue concentration gradients.

Authors:  M F Flessner; J D Fenstermacher; R L Dedrick; R G Blasberg
Journal:  Am J Physiol       Date:  1985-03

6.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

7.  Investigation about the penetration depth in the normal bladder wall and tumor by local instillation of mitomycin into the urinary bladder.

Authors:  B Aeikens; R Niermann; E Schindler
Journal:  Urol Int       Date:  1982       Impact factor: 2.089

8.  Analysis of drug penetration through the skin by the two-layer skin model.

Authors:  H Okamoto; F Yamashita; K Saito; M Hashida
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

9.  A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat.

Authors:  M F Flessner; R L Dedrick; J S Schultz
Journal:  Am J Physiol       Date:  1985-03

10.  Regional noradrenergic and cholinergic neurochemistry in the rat urinary bladder: effects of age.

Authors:  J M Johnson; K A Skau; M C Gerald; L J Wallace
Journal:  J Urol       Date:  1988-03       Impact factor: 7.450

View more
  10 in total

Review 1.  Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Authors:  M S Highley; A T van Oosterom; R A Maes; E A De Bruijn
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogs.

Authors:  Leijun Hu; M Guillaume Wientjes; Jing Li; Jessie L-S Au
Journal:  AAPS J       Date:  2010-07-13       Impact factor: 4.009

3.  Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.

Authors:  R Paroni; A Salonia; A Lev; L F Da Pozzo; G Cighetti; F Montorsi; P Rigatti; R Colombo
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

4.  Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.

Authors:  J T Dalton; D Zhou; A Mukherjee; D Young; E A Tolley; A L Golub; M C Meyer
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

5.  Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.

Authors:  Andrew S Mikhail; Ayele H Negussie; William F Pritchard; Dieter Haemmerich; David Woods; Ivane Bakhutashvili; Juan Esparza-Trujillo; Sam J Brancato; John Karanian; Piyush K Agarwal; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2017-05-10       Impact factor: 3.914

6.  Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.

Authors:  Ze Lu; Teng-Kuang Yeh; Jie Wang; Ling Chen; Greg Lyness; Yan Xin; M Guillaume Wientjes; Valerie Bergdall; Guillermo Couto; Francisco Alvarez-Berger; Carrie E Kosarek; Jessie L-S Au
Journal:  J Urol       Date:  2011-02-19       Impact factor: 7.450

Review 7.  Intraperitoneal therapy for peritoneal cancer.

Authors:  Ze Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

8.  Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.

Authors:  M G Wientjes; R A Badalament; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.

Authors:  E Gupta; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

Review 10.  Intravesical chemotherapy in non-muscle-invasive bladder cancer.

Authors:  Sima P Porten; Michael S Leapman; Kirsten L Greene
Journal:  Indian J Urol       Date:  2015 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.